Literature DB >> 10425565

Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.

S Kato1, M Saito, A Hirano, E Ohama.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that primarily involves the motor neuron system. Of all patients with ALS, approximately 5%-10% of them are familial and most of the others are sporadic. Superoxide dismutase 1 (SOD1) gene mutations are shown to be associated with about 20% of familial ALS (FALS) patients. FALS is neuropathologically classified into two subtypes: classical FALS in which degeneration is restricted to only motor neurons and FALS which is characterized by the degeneration of the posterior column in addition to the lesion of the motor neuron system. The neuronal Lewy body-like hyaline inclusion (LBHI) is a characteristic neuropathological marker of mutant SOD1-linked FALS with posterior column involvement. Inclusions similar to the neuronal LBHIs have been discovered in astrocytes in certain patients with FALS exhibiting SOD1 gene mutations. The purpose of this review is to discuss the novel neuropathological significance of the astrocytic hyaline inclusions (Ast-HIs) and neuronal LBHIs in brain tissues from individuals with the posterior-column-involvement-type FALS with SOD1 gene mutations. In hematoxylin and eosin preparations, both Ast-HIs and neuronal LBHIs are eosinophilic inclusions and sometimes show eosinophilic cores with paler peripheral halos. Immunohistochemically, both inclusions are intensely positive for SOD1. At the ultrastructural level, both inclusions consist of approximately 15-25 nm-sized granule-coated fibrils and granular materials. Immunoelectron microscopically, these abnormal granule-coated fibrils and granular materials are positive for SOD1. Therefore, the FALS disease process originating from SOD1 gene mutations occurs in astrocytes as well as neurons and is involved in the formation of both inclusions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425565     DOI: 10.14670/HH-14.973

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

Review 1.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

2.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

Review 3.  ER stress and unfolded protein response in amyotrophic lateral sclerosis.

Authors:  Kohsuke Kanekura; Hiroaki Suzuki; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2009-01-30       Impact factor: 5.590

4.  Effects of maturation on the conformational free-energy landscape of SOD1.

Authors:  Robert M Culik; Ashok Sekhar; Jayashree Nagesh; Harmeen Deol; Jessica A O Rumfeldt; Elizabeth M Meiering; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-26       Impact factor: 11.205

5.  An in vitro model for Lewy body-like hyaline inclusion/astrocytic hyaline inclusion: induction by ER stress with an ALS-linked SOD1 mutation.

Authors:  Satoru Yamagishi; Yoshihisa Koyama; Taiichi Katayama; Manabu Taniguchi; Junichi Hitomi; Masaaki Kato; Masashi Aoki; Yasuto Itoyama; Shinsuke Kato; Masaya Tohyama
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

6.  Cu/Zn-superoxide dismutase forms fibrillar hydrogels in a pH-dependent manner via a water-rich extended intermediate state.

Authors:  Noriko Fujiwara; Michiru Wagatsuma; Naoto Oba; Daisaku Yoshihara; Eiichi Tokuda; Haruhiko Sakiyama; Hironobu Eguchi; Motoko Ichihashi; Yoshiaki Furukawa; Tadashi Inoue; Keiichiro Suzuki
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.